Docket

36655

Apotex Inc., et al. v. Merck & Co. Inc., et al.

(Federal) (Civil) (By Leave)

(Sealing order)

Judgments on applications for leave to appeal are rendered by the Court, but are not necessarily unanimous.

Proceedings
Date Proceeding Filed By
(if applicable)
2016-04-19 Close file on Leave
2016-04-15 Copy of formal judgment sent to Registrar of the Court of Appeal and all parties
2016-04-15 Judgment on leave sent to the parties
2016-04-14 Judgment of the Court on the application for leave to appeal, The applications for leave to appeal from the judgments of the Federal Court of Appeal, in docket Number A-242-13, 2015 FCA 171, dated July 23, 2015, and November 6, 2015, are both dismissed with costs.
Dismissed, with costs
2016-02-29 All materials on application for leave submitted to the Judges, CJ Mo Ga
2016-02-18 Applicant's reply to respondent's argument, (Book Form), SECOND APPLICATION., Completed on: 2016-02-18, (Electronic version filed on 2016-02-18) Apotex Inc.
2016-02-08 Notice of name, (Letter Form), (Electronic version filed on 2016-02-08) Merck & Co. Inc.
2016-02-08 Certificate (on limitations to public access), (Letter Form), (Electronic version filed on 2016-02-08) Merck & Co. Inc.
2016-02-08 Respondent's response on the application for leave to appeal, (Book Form), SECOND APPLICATION., Completed on: 2016-02-08, (Electronic version filed on 2016-02-08) Merck & Co. Inc.
2016-01-13 Letter acknowledging receipt of a complete application for leave to appeal, SECOND APPLICATION.
2016-01-06 Notice of application for leave to appeal, (Letter Form), SECOND APPLICATION., Completed on: 2016-01-06, (Electronic version filed on 2016-01-06) Apotex Inc.
2016-01-05 Notice of name, (Letter Form), (Electronic version filed on 2016-01-06) Apotex Inc.
2016-01-05 Certificate (on limitations to public access), (Letter Form), Amended certificate received 2016-01-22., (Electronic version filed on 2016-01-06) Apotex Inc.
2016-01-05 Application for leave to appeal, (Book Form), (4 volumes), SECOND APPLICATION : 6 Sealed envelope of Protected documents containing tabs 11C, D & E., Completed on: 2016-01-05, (Electronic version filed on 2016-01-06) Apotex Inc.
2015-11-12 Correspondence received from, (Letter Form), Cousel for the Respondents re: motion for reconsideration of the Judment from which leave to appeal is sought was dismissed., (Electronic version filed on 2015-11-12) Merck & Co. Inc.
2015-11-12 Applicant's reply to respondent's argument, (Book Form), Completed on: 2015-11-16, (Electronic version filed on 2015-11-12) Apotex Inc.
2015-11-02 Respondent's response on the application for leave to appeal, (Book Form), Completed on: 2015-11-02, (Electronic version filed on 2015-11-02) Merck & Co. Inc.
2015-11-02 Certificate (on limitations to public access), (Letter Form), (Electronic version filed on 2015-11-02) Merck & Co. Inc.
2015-11-02 Notice of name, (Letter Form), (Electronic version filed on 2015-11-02) Merck & Co. Inc.
2015-10-30 Correspondence received from, Heather Hill dated 2015-10-30. Re: Christopher Rootham will be acting as agent for the applicants Apotex Inc.
2015-10-01 Letter acknowledging receipt of an incomplete application for leave to appeal, FIRST APPLICATION : file opened 2015-10-01.
2015-09-29 Certificate (on limitations to public access), (Letter Form), (Electronic version filed on 2015-09-29) Apotex Inc.
2015-09-29 Notice of name, (Letter Form), (Electronic version filed on 2015-09-29) Apotex Inc.
2015-09-29 Application for leave to appeal, (Book Form), (3 volumes), FIRST APPLICATION : Sealed envelope containing Tab 9J. Service by E-mail consented by counsel for Respondent, Merck 2015-10-05., Completed on: 2015-10-05, (Electronic version filed on 2015-09-29) Apotex Inc.